Accessibility Menu
Sensus Healthcare logo

Sensus Healthcare

(NASDAQ) SRTS

Current Price$3.03
Market Cap$49.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)-48%
5 Year-23%
1 Year-32%
1 Month+11%
Sensus Healthcare last closing stock price
MetricPriceDate
Last closeUSD 3.022026-07-17
Sensus Healthcare stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.98%USD 3.052026-07-10
1 month+10.62%USD 2.732026-06-17
3 month-32.74%USD 4.492026-04-17
Year to date-24.12%USD 3.982025-12-31
1 year-31.98%USD 4.442025-07-17
3 year-5.03%USD 3.182023-07-18
5 year-23.16%USD 3.932021-07-16
Since inception-48.38%USD 5.852016-07-26

Sensus Healthcare Financials at a Glance

Market Cap

$49.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$22.53M

Net Income (TTM)

-$7.77M

EPS (TTM)

-$0.47

P/E Ratio

-6.36

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$3.03

Volume

18,576.693

Open

$3.01

Previous Close

$3.02

Daily Range

$2.97 - $3.04

52-Week Range

$2.66 - $5.92

Estimated Earnings Date

Aug 6, 2026

SRTS News

Foolcom-Featured.png

Sensus (SRTS) Q2 Revenue Falls 21%

Motley Fool Markets TeamAug 7, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sensus Healthcare

Sensus Healthcare makes devices that treat skin conditions without surgery. Its main products help doctors treat skin cancer and scars in clinics. These devices offer patients a non-invasive option for care.

Gadgets That Zap, Not Cut: Products and Services

  • Superficial Radiation Therapy (SRT) Devices: Non-surgical treatment for skin cancers and keloids.
  • SRT-100 Vision: Adds ultrasound imaging for precise tumor targeting; used by dermatologists and clinics.
  • Service Programs: Maintenance, repair, and system protection for device owners; includes Sentinel service program.
  • Equipment Leasing: Offers device rentals and personnel services to clinics; expands access for smaller practices.
  • Consumables and Accessories: Sells disposable safety items, lead shields, and applicator tips for device use.

Growth Spurts and Strategic Moves

  • Expanded equipment leasing and operational services through Sensus Healthcare Services, LLC in recent years.
  • Increased research and development spending for new device features in 2024-2025.
  • Subleased extra office space in 2025 to support growth plans.
  • Secured third-party manufacturing agreement for SRT-100 devices in 2025 to ensure supply.
  • Entered China market, with 8% of Q3 2025 revenue from this region.

Why Sensus Stands Out (Without Showing Off)

Sensus focuses on non-invasive skin treatments, offering alternatives to surgery for common skin cancers. Its integration of imaging and treatment planning in devices like SRT-100 Vision helps clinics deliver targeted care. The company’s business model combines device sales, leasing, and ongoing service, supporting recurring revenue streams.

Five Things You Need to Know

  • Gross margin fell to 39.7% in Q2 2025, from 58.7% a year earlier.
  • One U.S. customer made up 56% of Q2 2025 revenue.
  • Cash and cash equivalents were $22.2 million as of June 30, 2025.
  • No outstanding debt; $15 million available under a credit facility as of June 30, 2025.

Bottom Line

Sensus has evolved from device sales to a broader service and leasing model. The company’s focus on non-invasive skin treatments and recurring revenue streams shapes its current business profile.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

60

CEO

Joseph C. Sardano

Website

www.sensushealthcare.com

Headquarters

Boca Raton, FL 33487, US

SRTS Financials

Key Financial Metrics (TTM)

Gross Margin

37.75%

Operating Margin

-53.34%

Net Income Margin

-34.50%

Return on Equity

-15.79%

Return on Capital

-21.13%

Return on Assets

-15.08%

Earnings Yield

-15.72%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$49.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

16.46M

Volume

18.58K

Avg. Volume

58.92K

Financials (TTM)

Gross Profit

$8.51M

Operating Income

-$12.02M

EBITDA

-$8.01M

Operating Cash Flow

-$548.00K

Capital Expenditure

-$192.00K

Free Cash Flow

-$740.00K

Cash & ST Invst.

$18.33M

Total Debt

$407.00K

Sensus Healthcare Performance Analysis

Sensus Healthcare annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 44,532,00064.7%
20232023-12-31USD 24,405,000-45.2%
20242024-12-31USD 41,807,00071.3%
20252025-12-31USD 27,482,000-34.3%
Sensus Healthcare sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-12.3%
Q32025-09-30-5.9%
Q42025-12-31-28.3%
Q12026-03-31-31.3%
Sensus Healthcare annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 1.46484.5%
20232023-12-31USD 0.03-98.0%
20242024-12-31USD 0.411263.4%
20252025-12-31USD -0.47N/A
Sensus Healthcare sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3060.3%
Q32025-09-309.0%
Q42025-12-31-228.7%
Q12026-03-3115.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$3.39M

-59.3%

Gross Profit

$991.00K

-77.2%

Gross Margin

29.20%

N/A

Market Cap

$49.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$828.59K

N/A

Employees

60

N/A

Net Income

-$2.63M

-2.1%

EBITDA

-$4.14M

-78.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$18.33M

-3.9%

Total Debt

$407.00K

-37.8%

Accounts Receivable

$3.58M

-80.1%

Inventory

$16.50M

+66.3%

Long Term Debt

$140.00K

-65.7%

Short Term Debt

$267.00K

+8.5%

Return on Assets

-15.08%

N/A

Return on Invested Capital

-26.31%

N/A

Free Cash Flow

-$3.76M

-39.9%

Operating Cash Flow

-$3.75M

-40.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MDAISpectral AI, Inc.
$1.67+1.21%
BDMDBaird Medical Investment Holdings Limited
$1.06+0.95%
PETSPetMed Express, Inc.
$1.97-1.50%
TELATELA Bio, Inc.
$0.73-2.61%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.53-0.02%
NOKNokia
$10.12-0.03%
JOBYJoby Aviation
$7.23-0.01%
SOFISoFi Technologies
$17.28-0.00%

Questions About SRTS

What is the current price of Sensus Healthcare?

Sensus Healthcare is trading at $3.02 per share.

What is the 52-week range for Sensus Healthcare?

Over the past 52 weeks, Sensus Healthcare has traded between $2.66 and $5.92.

How much debt does Sensus Healthcare have?

As of the most recent reporting period, Sensus Healthcare reported total debt of $408.00K.

How much cash does Sensus Healthcare have on hand?

Sensus Healthcare reported $18.33M in cash and cash equivalents in its most recent financial results.

What is Sensus Healthcare’s dividend yield?

Sensus Healthcare does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services